Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

Clinical trial NCT00354120 · COMPLETED

Trial details

NCT number: NCT00354120
Sponsor: Gruppo Italiano Trapianto di Midollo Osseo
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Myeloblastic Leukemia Lymphoblastic Leukemia Myelodysplasia Chronic Myeloid Leukemia Myelofibrosis Lympho-proliferative Diseases

Start date: 2005-03-01
Primary completion: 2011-08-01
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.